Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Neurotherapeutics"
DOI: 10.1007/s13311-021-01108-4
Abstract: In the last 25 years, intravenous immunoglobulin (IVIg) has had a major impact in the successful treatment of previously untreatable or poorly controlled autoimmune neurological disorders. Derived from thousands of healthy donors, IVIg contains IgG1… read more here.
Keywords: intravenous immunoglobulin; neurology; chronic therapy; ivig ... See more keywords
Assessing the impact of single or short-term administration on a therapy's cost-effectiveness: a hypothetical disease-agnostic model.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2200102
Abstract: AIMS Assessing the value of single or short-term therapies (SSTs) within traditional cost-effectiveness analyses (CEAs) has been a topic of discussion as the number of SSTs increases, particularly regarding the effect of discounting on valuation.… read more here.
Keywords: equivalent chronic; sst; therapy; chronic therapy ... See more keywords
Chronic Therapy with Sucroferric Oxyhydroxide Does Not Affect Iron and Anemia Markers in Dialysis Patients
Sign Up to like & getrecommendations! Published in 2020 at "Blood Purification"
DOI: 10.1159/000505432
Abstract: Introduction: Sucroferric oxyhydroxide (SOH) is an iron-based phosphate binder (PB), and its use has been widely expanded since its initial approval in 2014. Based on the existing data, however, it remains yet unclear whether its… read more here.
Keywords: anemia; sucroferric oxyhydroxide; chronic therapy; iron ... See more keywords